Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Change in Account Payables: 2023-2024

Historic Change in Account Payables for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $11.7 million.

  • Zenas BioPharma's Change in Account Payables fell 157.61% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 160.79%. This contributed to the annual value of $11.7 million for FY2024, which is 2908.61% up from last year.
  • Per Zenas BioPharma's latest filing, its Change in Account Payables stood at $11.7 million for FY2024, which was up 2,908.61% from -$418,000 recorded in FY2023.
  • Zenas BioPharma's 5-year Change in Account Payables high stood at $11.7 million for FY2024, and its period low was -$418,000 during FY2023.
  • Its 2-year average for Change in Account Payables is $5.7 million, with a median of $5.7 million in 2023.
  • Data for Zenas BioPharma's Change in Account Payables shows a peak YoY soared of 2,908.61% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Change in Account Payables stood at -$418,000 in 2023, then soared by 2,908.61% to $11.7 million in 2024.